Association between myosteatosis and impaired glucose metabolism: A deep learning whole-body magnetic resonance imaging population phenotyping approach.
Matthias JungHanna RiederMarco ReisertSusanne RospleszczJohanna NattenmuellerAnnette PetersChristopher L SchlettFabian BambergJakob WeissPublished in: Journal of cachexia, sarcopenia and muscle (2024)
Quantitative SMFF, but not IMAT, is an independent predictor of impaired glucose metabolism, and discrimination is not significantly different from BMI, making it a promising alternative for the currently established approach. Automated methods such as the proposed model may provide a feasible option for opportunistic screening of myosteatosis and, thus, a low-cost personalized risk assessment solution.